/ Print /


Scammers, Fraudsters Capitalize on Opioid Addiction TreatmentA lack of national standards and less than optimal oversight of many inpatient, opioid addiction rehabilitation programs is raising questions about the level of services, personnel, and quality of care many patients are receiving.
Three Ways to Harness Consumer Feedback at Healthcare OrganizationsHealthcare organizations need a democratic approach to customer experience. Consider these three questions to maximize customer feedback.
What Roche’s Purchase of Flatiron Health Means for Health ExecsSwitzerland-based pharma company Roche’s $1.9 billion purchase of tech company Flatiron Health signifies Big Pharma’s need for data.
Two Ways to Take Charge of CAR T-Cell Therapy CostsSuccessful CAR T-cell therapy reimbursement begins with careful payer-provider collaboration and taking these two approaches.
Needless Antipsychotic Prescribing Runs Rampant in Nursing HomesA study from Human Rights Watch has eye-opening findings about antipsychotic drug prescribing in U.S. nursing homes.
Walgreens-AmerisourceBergen Deal: 3 TakeawaysRetail drug chain giant Walgreens made a takeover approach to drug distributor AmerisourceBergen. Here’s what industry watchers want you to know about it.
Twelve Must-Have Apps for Healthcare ExecutivesWe asked the Managed Healthcare Executive board to share their favorite app—for work or for play. Here’s what they said.
Six Ways to Support Healthcare Staff During DownsizingThe healthcare landscape is transforming. Here are six considerations to help your talent during restructuring, downsizing, and other transitions.
Three Ways Healthcare Organizations Can Improve Care ManagementHere are three strategies to navigate toward next-generation care management and increase member engagement in the process
Three Barriers to Biosimilar AdoptionUnderstanding the key barriers to biosimilar adoption in the U.S. is the first step managed care executives can take to overcome these obstacles, according to a Trinity Parners report.